Epicardial substrate ablation in high-risk brugada syndrome patients: systematic review and single-arm meta-analysis
Int. j. cardiovasc. sci. (Impr.); 37 (suppl.9), 2024
INTRODUCTION: Brugada syndrome (BrS) is a genetic heart disease that predisposes individuals to malignant ventricular arrhythmias and sudden cardiac death (SCD). Although implantable cardioverter-defibrillators (ICDs) and quinidine are primary treatments, recurrent BrS-triggered cardiac ventricular arrhy...